Related Experiment Video
Updated: Jul 8, 2025

06:03
Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
Published on: July 15, 2019
8.0K
Analysis, Modeling, and Target-Specific Predictions of Linear Peptides Inhibiting Virus Entry
Boris Vishnepolsky1, Maya Grigolava1, Andrei Gabrielian2
1Ivane Beritashvili Center of Experimental Biomedicine, Tbilisi 0160, Georgia.
ACS Omega
|December 11, 2023
Summary
Researchers developed a machine learning model to identify new virus entry inhibitory peptides (VEIPs). This tool enhances antiviral peptide discovery by considering viral envelope proteins, achieving high prediction accuracy.
Area of Science:
- Biochemistry
- Computational Biology
- Virology
Background:
- Antiviral peptides (AVPs) combat viruses via diverse mechanisms.
- Virus entry inhibitory peptides (VEIPs) specifically block enveloped viruses from infecting cells.
- Increasing VEIP data necessitates advanced prediction methods.
Purpose of the Study:
- To develop the first target-specific machine learning model for predicting novel VEIPs.
- To improve VEIP prediction by incorporating viral envelope protein attributes alongside peptide sequence characteristics.
- To address data scarcity for specific viral strains and enhance predictive power.
Main Methods:
- Developed a machine learning model integrating peptide sequence features and target virus envelope protein attributes.
- Utilized 10x10-fold cross-validation on a training dataset for model evaluation.
- Assessed model performance on an independent test set.
Main Results:
- The model achieved 87.33% accuracy and an MCC of 0.76 during cross-validation.
- On an independent test set, the model demonstrated 90.91% accuracy and an MCC of 0.81.
- A computational tool for automated VEIP prediction was created.
Conclusions:
- The developed model accurately predicts VEIPs, outperforming previous methods by integrating virus-specific information.
- This approach effectively overcomes data limitations for novel viral strains.
- The freely available tool facilitates accelerated discovery of potential antiviral therapeutics.

